Vanda Gets FDA Approval For Fanapt Marketing Exclusivity
June 15, 2016 at 07:37 AM EDT
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) revealed that the U.S. Food and Drug Administration has granted three years of marketing ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.